-
Autor
Andres, Mara 1 Attarbaschi, Andishe 1 Balduzzi, Adriana 1 Beishuizen, Auke 1 Bubanska, Eva 1 Buechner, Jochen 1 Burke, G A Amos 1 Burkhardt, Birgit 1 Chiang, Alan Kwok Shing 1 Csoka, Monika 1 Donska, Svetlana 1 Fedorova, Alina 1 Garnier, Nathalie 1 Hazar, Volkan 1 Herbrueggen, Heidi 1 Hjalgrim, Lisa Lyngsie 1 Kabickova, Edita 1 Koeppen, Kristin 1 Krivan, Gergely 1 Lazic, Jelena 1
-
Pracoviště
2nd Department of Pediatrics Semmelwe... 1 Belarusian Research Centre for Pediat... 1 Central Hospital of Southern Pest Nat... 1 Centre of Pediatric OncoHematology an... 1 Children's Cancer Centre National Cen... 1 Clinic of Pediatric Oncology and Hema... 1 Department for Hematology and Oncolog... 1 Department of Child and Woman Health ... 1 Department of Pediatric Haematology a... 1 Department of Pediatric Hematology On... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Oncology Hema... 1 Department of Pediatric Oncology Roya... 1 Department of Pediatric Oncology Univ... 1 Department of Pediatric Oncology Univ... 1 Department of Pediatric Oncology and ... 1 Department of Pediatric and Adolescen... 1
- Formát
- Publikační typ
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Autor
Andres, Mara 1 Attarbaschi, Andishe 1 Balduzzi, Adriana 1 Beishuizen, Auke 1 Bubanska, Eva 1 Buechner, Jochen 1 Burke, G A Amos 1 Burkhardt, Birgit 1 Chiang, Alan Kwok Shing 1 Csoka, Monika 1 Donska, Svetlana 1 Fedorova, Alina 1 Garnier, Nathalie 1 Hazar, Volkan 1 Herbrueggen, Heidi 1 Hjalgrim, Lisa Lyngsie 1 Kabickova, Edita 1 Koeppen, Kristin 1 Krivan, Gergely 1 Lazic, Jelena 1
-
Pracoviště
2nd Department of Pediatrics Semmelwe... 1 Belarusian Research Centre for Pediat... 1 Central Hospital of Southern Pest Nat... 1 Centre of Pediatric OncoHematology an... 1 Children's Cancer Centre National Cen... 1 Clinic of Pediatric Oncology and Hema... 1 Department for Hematology and Oncolog... 1 Department of Child and Woman Health ... 1 Department of Pediatric Haematology a... 1 Department of Pediatric Hematology On... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Hematology an... 1 Department of Pediatric Oncology Hema... 1 Department of Pediatric Oncology Roya... 1 Department of Pediatric Oncology Univ... 1 Department of Pediatric Oncology Univ... 1 Department of Pediatric Oncology and ... 1 Department of Pediatric and Adolescen... 1
- Formát
- Publikační typ
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
33923026
DOI
10.3390/cancers13092075
Knihovny.cz E-zdroje
Despite poor survival, controversies remain in the treatment for refractory or relapsed pediatric non-Hodgkin lymphoma (r/r NHL). The current project aimed to collect international experience on the re-induction treatment of r/r NHL, hematopoietic stem cell transplantation (HSCT), risk factors associated with outcome, and to suggest treatment recommendations. Inclusion criteria were (i) refractory disease, disease progression or relapse of any NHL subtype except anaplastic large cell lymphoma, (ii) age < 18 years at initial diagnosis, (iii) diagnosis in/after January 2000. Data from 639 eligible patients were evaluable. The eight-year probability of overall survival was 34 ± 2% with highly significant differences according to NHL subtypes: 28 ± 3% for 254 Burkitt lymphoma/leukemia, 50 ± 6% for 98 diffuse large B-cell lymphomas, 57 ± 8% for 41 primary mediastinal large B-cell lymphomas, 27 ± 3% for 177 T-lymphoblastic lymphomas, 52 ± 10% for 34 precursor-B-cell lymphoblastic lymphomas and 30 ± 9% for 35 patients with rare NHL subtypes. Subtype-specific factors associated with survival and treatment recommendations are suggested. There were no survivors without HSCT, except in few very small subgroups. Conclusions: There is an urgent need to further improve survival in r/r NHL. The current study provides the largest real-world series, which underlines the role of HSCT and suggests treatment recommendations.
- Publikační typ
- časopisecké články MeSH
Upřesnit dle MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.